Bharat's $1 rotavirus vaccine rolls out in India to challenge GSK, Merck

An article from FierceVaccines
March 10, 2015
Back in 2011, Indian company Bharat Biotech pledged to offer its rotavirus prospect at a price that undercut even discounted vaccines from GlaxoSmithKline ($GSK) and Merck ($MRK). Now, it's ready to make good on its promise.
The country has rolled out Bharat's three-dose vaccine, Rotavac, at a rate of around 60 rupees--or just under one U.S. dollar.
"Today's launch fortifies our mission to identify public health problems and make affordable life-saving vaccines to children wherever they are born," Bharat's chairman and managing director, Krishna Ella, said in a statement. 
Read more here
Common Disease Taxonomy: 
Common Vaccine Taxonomy: